Poor
Poorly Aligned
Patient Risk:
Low
Summary
The AI-generated claims are largely not supported by the provided prescribing information. The label contains pharmacokinetic data and a note about severe bronchospasm as an adverse reaction but has no content supporting excipients use, tablet/capsule/formulation claims, taste or palatability, dosage/administration details, or formulation-specific manufacturing properties. Overall alignment is poor.
Category Scores
Accurate Statements
Unsupported Statements
Mannitol is a sugar alcohol used as an excipient, or filler, in pharmaceutical products.
Not supported by label; 12.3 provides PK data only and does not mention excipients.
It is commonly found in tablets, capsules, and powders.
Not supported by label; PK data present but no formulation/form occurrence details.
Mannitol has low hygroscopicity (absorbs very little moisture from the air).
Not supported by label; no hygroscopicity data in PK section.
Low hygroscopicity improves the stability of the final dosage form.
Not supported by label; no stability/hygroscopicity discussion.
It has a pleasant, sweet taste.
Not supported by label; no taste information in PK data.
Its sweet taste can mask the bitter taste of some drugs.
Not supported by label; no taste-masking information.
Mannitol makes oral medications more palatable.
Not supported by label; no palatability information.
Mannitol can be compressed into tablets without sticking to machinery.
Not supported by label; no manufacturing/compatibility data.
Compression without sticking is a desirable characteristic for large-scale manufacturing.
Not supported by label; no manufacturing attribute data.
In tablets, mannitol is often used as a direct compression filler or as a binder.
Not supported by label; no formulation usage details.
For orally disintegrating tablets (ODTs), mannitol is a popular choice due to its fast disintegration properties.
Not supported by label; no specifics on ODTs or disintegration properties.
Mannitol provides a cooling sensation as it dissolves in the mouth.
Not supported by label; no sensory property information.
In powders and granules, mannitol can serve as a bulking agent to provide a sufficient volume for accurate dosing.
Not supported by label; no bulking/dosing formulation details.
Mannitol is utilized in nasal sprays and inhalation products, where its particle size and low reactivity are beneficial.
Not supported by label; PK data present but no explicit formulation routes beyond inhalation.
Mannitol can cause gastrointestinal upset, such as bloating or diarrhea, particularly when consumed in large quantities.
Not supported by label; adverse reactions section notes bronchospasm but not GI upset.
Mannitol is poorly absorbed in the digestive system and can draw water into the intestines.
Not supported by label; PK data reflect absorption via inhalation routes; no digestive osmotic data.
In individuals with certain medical conditions, such as those with galactosemia, mannitol is a safe alternative to lactose.
Not supported by label; no condition-specific discussions or alternatives.
The amount of mannitol present in a single dose of medication is typically small and unlikely to cause adverse effects for most individuals.
Not supported by label; adverse reactions section mentions bronchospasm; no dosing-safety statement.
Contradictions
Important Omissions
No on-label information regarding mannitol as an excipient, direct compression usage, ODT suitability, palatability effects, nasal/inhalation formulations, or general formulation claims.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
Claims are largely unsupported by label; the only on-label safety reference is severe bronchospasm noted in Adverse Reactions. Misaligned statements do not reflect additional labeled risks.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Poorly Aligned
Primary Issue
Claims largely extrapolate beyond the content of the provided label.
Suggested Improvement
Limit statements to information explicitly supported by the label (pharmacokinetics and listed adverse reaction). Do not assert excipient use, palatability, or formulation-specific properties without label support; provide citations to label sections when making on-label claims.